Evaluation of effect of cilostazol on cerebral glucose metabolism in patients with amnestic mild cognitive impairment and preclinical Alzheimer's disease with lacunar infarction.
Not Applicable
- Conditions
- amnestic mild cognitive impairment and preclinical Alzheimer's disease
- Registration Number
- JPRN-UMIN000006599
- Lead Sponsor
- Department of Psychiatry, Juntendo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
other anti-dementia drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MMSE,WMS-R,FDG-PET
- Secondary Outcome Measures
Name Time Method